Changes
!width="70" bgcolor=DodgerBlue|'''Players of inhibition'''
|- style="height:10px"
|bgcolor=sky blueLightCyan|US6664247
[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6664247.PN.&OS=PN/6664247&RS=PN/6664247 US6664247]
|bgcolor=sky blueLightCyan|Pyrazole compounds |bgcolor=sky blueLightCyan|GSK3
|-
|bgcolor=sky blueLightCyan|US6989385
[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6989385.PN.&OS=PN/6989385&RS=PN/6989385 US6989385]
|bgcolor=sky blueLightCyan|Pyrazole compounds |bgcolor=sky blueLightCyan|GSK3
|-
|bgcolor=sky blueLightCyan|WO2005012256
[http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO2005012256&F=0 WO2005012256]
|bgcolor=sky blueLightCyan|Pyrazole compounds |bgcolor=sky blueLightCyan|CDK,GSK3|-|bgcolor=LightCyan|US6974819[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6974819.PN.&OS=PN/6974819&RS=PN/6974819 US6974819]|bgcolor=LightCyan|Pyrimidine derivative|bgcolor=LightCyan|GSK3|-|bgcolor=LightCyan|US6743791[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6743791.PN.&OS=PN/6743791&RS=PN/6743791 US6743791]|bgcolor=LightCyan|Heterocyclic compounds|bgcolor=LightCyan|AKT3, GSK-3, ERK2|-|bgcolor=LightCyan|US20050277773[http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220050277773%22.PGNR.&OS=DN/20050277773&RS=DN/20050277773 US20050277773]|bgcolor=LightCyan|Pyrrolo[3,2-d]pyrimidine derivatives |bgcolor=LightCyan|GSK3|-|bgcolor=LightCyan|US20040072836[http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220040072836%22.PGNR.&OS=DN/20040072836&RS=DN/20040072836 US20040072836]|bgcolor=LightCyan|Aza-oxindole derivatives |bgcolor=LightCyan|GSK3, AKT, PKC|-|bgcolor=LightCyan|EP1477489[http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP1477489&F=0 EP1477489]|bgcolor=LightCyan|Pyrrolopyrimidine derivatives |bgcolor=LightCyan|GSK3|-|bgcolor=LightCyan|WO0056710[http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO0056710&F=0 WO0056710]|bgcolor=LightCyan|3-(Anilinomethylene) oxindoles |bgcolor=LightCyan|GSK3, AKT, PKC|-|bgcolor=LightCyan|WO2003011287[http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=WO03011287&F=0 WO2003011287]|bgcolor=LightCyan|Pyrazolon derivatives |bgcolor=LightCyan|GSK3, β-catenin|-|bgcolor=LightCyan|US6924141[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6924141.PN.&OS=PN/6924141&RS=PN/6924141 US6924141]|bgcolor=LightCyan|Lithium chloride, Wnt3/4/ 7 |bgcolor=LightCyan|β-catenin, GSK3, Wnt|-|bgcolor=LightCyan|US6706685[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6706685.PN.&OS=PN/6706685&RS=PN/6706685 US6706685]|bgcolor=LightCyan|Peptide sequence |bgcolor=LightCyan|β-catenin|-|bgcolor=LightCyan|US6683048[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6683048.PN.&OS=PN/6683048&RS=PN/6683048 US6683048]|bgcolor=LightCyan|Peptide sequence |bgcolor=LightCyan|α-catenin, β-catenin|-|bgcolor=LightCyan|US6677116[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6677116.PN.&OS=PN/6677116&RS=PN/6677116 US6677116]|bgcolor=LightCyan|Peptide sequence LXXLL|bgcolor=LightCyan|β-catenin|-|bgcolor=LightCyan|US6303576[http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6303576.PN.&OS=PN/6303576&RS=PN/6303576 US6303576]|bgcolor=LightCyan|Peptide sequence LXXLL|bgcolor=LightCyan|β-catenin
|}
== Questions Dolcera Answers ==
Anonymous user
